Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides

  1. Guisado-Gil, A.B.
  2. Muñoz-Burgos, M.
  3. Ortega-Eslava, A.
  4. García-Hernández, F.J.
  5. Santos-Ramos, B.
Journal:
Farmacia Hospitalaria

ISSN: 2171-8695,  1130-6343

Year of publication: 2020

Volume: 44

Issue: 2

Pages: 46-50

Type: Article

DOI: 10.7399/FH.11287 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus